[Upcoming Webinar] Akashi Provides Update on HT-100

Event Details

[Upcoming Webinar] Akashi Provides Update on HT-100

Time: March 27, 2017 from 1:30pm to 2:30pm
Location: Online Webinar - Eastern Time Zone
Website or Map: https://www.readytalk.com/join
Phone: 1.866.740.1260 -- Access code: 9449985
Event Type: webinar
Organized By: PPMD
Latest Activity: Mar 23, 2017

Export to Outlook or iCal (.ics)

Event Description

Monday, March 27 at 1:30 PM EST

Please join Parent Project Muscular Dystrophy and Akashi Therapeutics as we host a webinar Monday, March 27 at 1:30 PM ET to discuss HT-100 and next steps for the clinical program.

Akashi CEO Marc Blaustein will present data from the previous clinical program of HT-100 and discuss FDA’s recent decision to allow the clinical development of HT-100 to resume, and leave time for discussion and fielding of questions.


  • Pat Furlong
    Founding President & CEO, Parent Project Muscular Dystrophy
  • Annie Kennedy
    Senior Vice President of Legislation and Public Policy, Parent Project Muscular Dystrophy
  • Marc Blaustein
    CEO, Akashi Therapeutics

To Participate:

  1. Visit ReadyTalk.com and use access code 9449985. (Be sure to test your computer beforehand)
  2. Audio Dial-In Information:
    • U.S. & Canada: Dial 1.866.740.1260 and use the Access Code 9449985
    • Outside the U.S. and Canada: Lookup your number

Submit Questions:

Please submit questions in advance to ryan@parentprojectmd.org, with “Akashi Webinar” in the subject line by Friday, March 24th at 5pm eastern.

Comment Wall


RSVP for [Upcoming Webinar] Akashi Provides Update on HT-100 to add comments!

Join PPMD Community

Attending (2)

Need help using this community site? Visit Ning's Help Page.



© 2023   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service